Travere Therapeutics (TVTX)
(Delayed Data from NSDQ)
$16.68 USD
+0.72 (4.51%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $16.68 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Travere Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
TVTX 16.68 +0.72(4.51%)
Will TVTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TVTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TVTX
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Compared to Estimates, Travere (TVTX) Q1 Earnings: A Look at Key Metrics
TVTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Travere Therapeutics (TVTX) Reports Q1 Loss, Tops Revenue Estimates
Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Novavax (NVAX) Soars 11.4%: Is Further Upside Left in the Stock?
Other News for TVTX
Earnings Scheduled For August 6, 2025
Earnings To Watch: Travere Therapeutics Inc (TVTX) Reports Q2 2025 Result
Travere Therapeutics Inc (TVTX) Announces Participation in Upcoming Investor Conferences | TVTX ...
Travere Therapeutics to Participate at Upcoming Investor Conferences | TVTX Stock News
Earnings Preview: Travere Therapeutics